Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.01 BRL | -14.36% | -8.73% | +142.39% |
May. 16 | Biomm S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 18 | Biocon Signs Licensing and Supply Pact with Biomm to Commercialize Generic Ozempic in Brazil | MT |
Sales 2022 | 105M 19.51M | Sales 2023 | 118M 21.97M | Capitalization | 470M 87.35M |
---|---|---|---|---|---|
Net income 2022 | -92M -17.1M | Net income 2023 | -81M -15.06M | EV / Sales 2022 | 5.9 x |
Net Debt 2022 | 67.72M 12.59M | Net Debt 2023 | 125M 23.22M | EV / Sales 2023 | 5.03 x |
P/E ratio 2022 |
-5.37
x | P/E ratio 2023 |
-5.93
x | Employees | 130 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 33.88% |
1 day | -14.36% | ||
1 week | -8.73% | ||
Current month | -19.94% | ||
1 month | -11.66% | ||
3 months | +55.49% | ||
6 months | +115.54% | ||
Current year | +142.39% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | - | |
Director of Finance/CFO | - | 19-04-15 | |
Luciano Vilela
CTO | Chief Tech/Sci/R&D Officer | - | 14-02-19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 74 | 14-01-31 | |
Director/Board Member | 84 | 15-10-12 | |
Director/Board Member | 81 | 13-12-15 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-14 | 14.01 | +0.07% | 128,700 |
24-06-13 | 14 | -1.48% | 141,600 |
24-06-12 | 14.21 | -1.52% | 129,800 |
24-06-11 | 14.43 | +3.07% | 446,600 |
24-06-10 | 14 | -8.79% | 351,700 |
Delayed Quote Sao Paulo, June 14, 2024 at 04:06 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+142.39% | 332M | |
+18.15% | 124B | |
+18.02% | 112B | |
+5.07% | 22.94B | |
-12.75% | 22.22B | |
-9.86% | 17.02B | |
-14.97% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |
- Stock Market
- Equities
- BIOM3 Stock